Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

13 questions · 13 findings · 2 reviews · Kidney and Transplant

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 3 · 23.1%Low 8 · 61.5%Moderate 1 · 7.7%High 1 · 7.7%

Antibody vs other antibody (stratified by antibody type)

Graft loss censored for death · kidney transplant recipients: steroid‐resistant rejection episodes

Antibody showed no clear difference in graft loss censored for death compared with other antibody (stratified by antibody type) (low certainty).

1 finding from 1 review

Rituximab (B cell) + steroid vs steroids

Graft loss or death with a functioning graft · kidney transplant recipients: first rejection episode

Rituximab (B cell) + steroid showed no clear difference in graft loss or death with a functioning graft compared with steroid alone (moderate certainty).

1 finding from 1 review

Antibody vs other antibody (stratified by antibody type)

Graft loss or death with a functioning graft · kidney transplant recipients: steroid‐resistant rejection episodes

Antibody showed no clear difference in graft loss or death with a functioning graft compared with other antibody (stratified by antibody type) (low certainty).

1 finding from 1 review

Antibody (T cell) vs steroids

Graft loss or death with a functioning graft · kidney transplant recipients: first rejection episode

Antibody (T cell) showed no clear difference in graft loss or death with a functioning graft compared with steroid (stratified by antibody type) (low certainty).

1 finding from 1 review

Antibody (T cell) + steroid vs steroids

Graft loss or death with a functioning graft · kidney transplant recipients: first rejection episode

It is very uncertain whether antibody (T cell) + steroid changes graft loss or death with a functioning graft compared with steroid alone (very low certainty).

1 finding from 1 review